These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 30371322

  • 1. Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts.
    Jana S, Zhang H, Lopaschuk GD, Freed DH, Sergi C, Kantor PF, Oudit GY, Kassiri Z.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e010427. PubMed ID: 30371322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.
    Woulfe KC, Siomos AK, Nguyen H, SooHoo M, Galambos C, Stauffer BL, Sucharov C, Miyamoto S.
    J Card Fail; 2017 Apr 02; 23(4):314-324. PubMed ID: 27890770
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure.
    Mujumdar VS, Tyagi SC.
    J Hypertens; 1999 Feb 02; 17(2):261-70. PubMed ID: 10067796
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy.
    Sivakumar P, Gupta S, Sarkar S, Sen S.
    Mol Cell Biochem; 2008 Jan 02; 307(1-2):159-67. PubMed ID: 17849172
    [Abstract] [Full Text] [Related]

  • 8. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN, Ziemann M, Kiriazis H, Su Y, Thomas Z, Lu Q, Donner DG, Zhao WB, Rafehi H, Sadoshima J, McMullen JR, El-Osta A, Du XJ.
    Am J Physiol Heart Circ Physiol; 2019 Jan 01; 316(1):H45-H60. PubMed ID: 30387702
    [Abstract] [Full Text] [Related]

  • 9. Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure.
    Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, Lewis W, Heroux A, Samarel AM.
    J Card Fail; 2013 Apr 01; 19(4):283-94. PubMed ID: 23582094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes.
    Franssen C, Kole J, Musters R, Hamdani N, Paulus WJ.
    Circ Heart Fail; 2017 Mar 01; 10(3):e003626. PubMed ID: 28242778
    [Abstract] [Full Text] [Related]

  • 12. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.
    Rubiś P, Wiśniowska-Śmialek S, Wypasek E, Biernacka-Fijalkowska B, Rudnicka-Sosin L, Dziewiecka E, Faltyn P, Khachatryan L, Karabinowska A, Kozanecki A, Tomkiewicz-Pająk L, Podolec P.
    Inflamm Res; 2016 Dec 01; 65(12):941-949. PubMed ID: 27516211
    [Abstract] [Full Text] [Related]

  • 13. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
    Rouet-Benzineb P, Buhler JM, Dreyfus P, Delcourt A, Dorent R, Perennec J, Crozatier B, Harf A, Lafuma C.
    Eur J Heart Fail; 1999 Dec 01; 1(4):337-52. PubMed ID: 10937947
    [Abstract] [Full Text] [Related]

  • 14. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target.
    Spinale FG, Coker ML, Bond BR, Zellner JL.
    Cardiovasc Res; 2000 May 01; 46(2):225-38. PubMed ID: 10773226
    [Abstract] [Full Text] [Related]

  • 15. Serum circulating proteins from pediatric patients with dilated cardiomyopathy cause pathologic remodeling and cardiomyocyte stiffness.
    Jeffrey DA, Pires Da Silva J, Garcia AM, Jiang X, Karimpour-Fard A, Toni LS, Lanzicher T, Peña B, Miyano CA, Nunley K, Korst A, Sbaizero O, Taylor MR, Miyamoto SD, Stauffer BL, Sucharov CC.
    JCI Insight; 2021 Oct 08; 6(19):. PubMed ID: 34383712
    [Abstract] [Full Text] [Related]

  • 16. Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.
    Nakano SJ, Walker JS, Walker LA, Li X, Du Y, Miyamoto SD, Sucharov CC, Garcia AM, Mitchell MB, Ambardekar AV, Stauffer BL.
    Am J Physiol Heart Circ Physiol; 2019 Dec 01; 317(6):H1221-H1230. PubMed ID: 31625780
    [Abstract] [Full Text] [Related]

  • 17. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar 01; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M, Schwinger RH, Schnabel P, Schiffer F, van Gelder I, Bavendiek U, Südkamp M, Kuhn-Regnier F, Böhm M.
    J Mol Med (Berl); 1996 Jun 01; 74(6):321-32. PubMed ID: 8862513
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.